SEC Form 4 · accession 0001179110-15-002934
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Felicia I Ladin
Officer — SVP & Treasurer
Period of report
Feb 17, 2015
Accepted (ET)
Feb 19, 2015 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2015 | A | 25,000 | $16.70 | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $16.70 | Feb 17, 2015 | A | 75,000 | A | — | Feb 17, 2025 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Option that is exercisable as to 1/4th of the shares annually on the anniversary date of the grant for each of the next four years.